Combined administration of EGCG and IL-1 receptor antagonist efficiently downregulates IL-1-induced tumorigenic factors in U-2 OS human osteosarcoma cells

Author:      

Publisher: Spandidos Publications

ISSN: 1019-6439

Source: International Journal of Oncology, Vol.41, Iss.2, 2012-01, pp. : 753-758

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content